Managed care (Langhorne, Pa.)
[No authors listed]
PMID: 22259880
Manag Care. 2011 Dec;20(12):69.
No abstract available.
Cite
Seven therapeutic categories account for most drug cost increases. Manag Care. 2011;20(12):69
(2011). Seven therapeutic categories account for most drug cost increases. Managed care (Langhorne, Pa.), 20(12), 69.
"Seven therapeutic categories account for most drug cost increases." Managed care (Langhorne, Pa.) vol. 20,12 (2011): 69.
Seven therapeutic categories account for most drug cost increases. Manag Care. 2011 Dec;20(12):69. PMID: 22259880.
Copy
Download .nbib
British journal of clinical pharmacology
Rawlins MD.
PMID: 22404227
Br J Clin Pharmacol. 2012 Jun;73(6):855-60. doi: 10.1111/j.1365-2125.2012.04263.x.
The fourth hurdle, the requirement that pharmaceutical manufacturers can demonstrate that their new products represent good value for money as well as being of good quality, effective and safe, is increasingly being required by healthcare systems. In crossing this...
Cite
Rawlins MD. Crossing the fourth hurdle. Br J Clin Pharmacol. 2012;73(6):855-60doi: 10.1111/j.1365-2125.2012.04263.x.
Rawlins, M. D. (2012). Crossing the fourth hurdle. British journal of clinical pharmacology, 73(6), 855-60. https://doi.org/10.1111/j.1365-2125.2012.04263.x
Rawlins, Michael D. "Crossing the fourth hurdle." British journal of clinical pharmacology vol. 73,6 (2012): 855-60. doi: https://doi.org/10.1111/j.1365-2125.2012.04263.x
Rawlins MD. Crossing the fourth hurdle. Br J Clin Pharmacol. 2012 Jun;73(6):855-60. doi: 10.1111/j.1365-2125.2012.04263.x. PMID: 22404227; PMCID: PMC3391507.
Copy
Download .nbib
Bulletin de l'Academie nationale de medecine
Sebbag R.
PMID: 18666459
Bull Acad Natl Med. 2007 Nov;191(8):1601-2.
As a responsible player in the global pharmaceutical industry, Sanofi-Aventis recognizes its special responsibility to provide poor countries with access to drugs and vaccines. This is a key component of the Group's approach to sustainable development. As such, the...
Cite
Sebbag R. Relever le défi de l'accès au médicament dans les pays du Sud. [Drug access in poor countries]. Bull Acad Natl Med. 2007;191(8):1601-2
Sebbag, R. (2007). Relever le défi de l'accès au médicament dans les pays du Sud. [Drug access in poor countries]. Bulletin de l'Academie nationale de medecine, 191(8), 1601-2.
Sebbag, Robert. "Relever le défi de l'accès au médicament dans les pays du Sud." [Drug access in poor countries]. Bulletin de l'Academie nationale de medecine vol. 191,8 (2007): 1601-2.
Sebbag R. Relever le défi de l'accès au médicament dans les pays du Sud. [Drug access in poor countries]. Bull Acad Natl Med. 2007 Nov;191(8):1601-2. French. PMID: 18666459.
Copy
Download .nbib
